2Haglund C,Lundin J,Kuusela P,et al. CA242,a new tumout ma rker for pancreatic cancer:a comparison with CA19-9,CAS0 and CEA. Br J Cancer, 1994,70: 487-492
3Pasanen PA,Eskelinen M, Partanen K,et al. Clinical evaluation of a new serum tumour marker CA242 in pancreatic carcinoma. Br J Cancer, 1992,65: 731-734
4Rothlin MA,Joller H,Largiader F. CA242 is a new tumour mar ker for pancreatic cancer. Cancer, 1993,71: 701-707
5Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J C1in,1996,46:5-27
6Lowenfels AB,Maisonneuve P,DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst, 1997,89: 442-444
7Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993, 328:1433-1437
8Ohashi K,Takagi K. ERCP and imaging diagnosis of pancreatic cancer. Gastrointest Endosc, 1997,77:1493-1495
9Permert J,Larsson J,Westermark HT, et al. Islet amyloid poly peptide in patients with pancreatic cancer and diabetes. N Engl J Med,1994,330:313-318
10Everhart J,Wright D. Diabetes melitus as a risk factor for pan creatic cancer. JAMA,1995,273:1605-1609
8Anthuber M, Schauer R, Jauch KW, et al. Experiences with liver transplantation and liver transplantation combined with Whipple's operation in Klatskin tumor [J]. Langenbecks Arch Chir Suppl Kongressbd,1996,113: 413-415.
9Varotti G, Gondolesi GE, Roayaie S, et al. Combined aduh-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocareinoma in a patient with primary sclerosing cholangitis[J]. J Am Coll Surg,2003,197(5):765-769.
10Perez Saborido B, Meneu JC, Moreno E, et al. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?[J]. Am J Surg,2005, 190(3):383-387.
